The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Drug Coated Stent Market Research Report 2025

Global Drug Coated Stent Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1675204

No of Pages : 116

Ask Your Query
Synopsis
The global Drug Coated Stent market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Drug Coated Stent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Coated Stent.
Report Scope
The Drug Coated Stent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Coated Stent market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Coated Stent manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Biosensors International
Abbott Laboratories
Advantec Vascular
B. Braun
Biosensors
Biotronik
Blue Medical
Boston Scientific
DISA Vascular
Essen
Medtronic Vascular
MicroPort Medical
MIV Therapeutics
Orbusneich
Promed Medical
Relisys Medical
Reva Medical
Sahajanand
Sino Medical
Sorin
Terumo Medical
Segment by Type
Everolimus-Coated Stent
Zotarolimus-Coated Stent
Ridaforolimus-Coated Stent
SYNERGY Coated Stent
Orsiro Coated Stent
Segment by Application
Angioplasty
Restenosis
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Drug Coated Stent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Drug Coated Stent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Drug Coated Stent Market Overview
1.1 Product Overview and Scope of Drug Coated Stent
1.2 Drug Coated Stent Segment by Type
1.2.1 Global Drug Coated Stent Market Value Comparison by Type (2024-2030)
1.2.2 Everolimus-Coated Stent
1.2.3 Zotarolimus-Coated Stent
1.2.4 Ridaforolimus-Coated Stent
1.2.5 SYNERGY Coated Stent
1.2.6 Orsiro Coated Stent
1.3 Drug Coated Stent Segment by Application
1.3.1 Global Drug Coated Stent Market Value by Application: (2024-2030)
1.3.2 Angioplasty
1.3.3 Restenosis
1.4 Global Drug Coated Stent Market Size Estimates and Forecasts
1.4.1 Global Drug Coated Stent Revenue 2019-2030
1.4.2 Global Drug Coated Stent Sales 2019-2030
1.4.3 Global Drug Coated Stent Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Drug Coated Stent Market Competition by Manufacturers
2.1 Global Drug Coated Stent Sales Market Share by Manufacturers (2019-2024)
2.2 Global Drug Coated Stent Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Drug Coated Stent Average Price by Manufacturers (2019-2024)
2.4 Global Drug Coated Stent Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Drug Coated Stent, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Drug Coated Stent, Product Type & Application
2.7 Drug Coated Stent Market Competitive Situation and Trends
2.7.1 Drug Coated Stent Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Drug Coated Stent Players Market Share by Revenue
2.7.3 Global Drug Coated Stent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Drug Coated Stent Retrospective Market Scenario by Region
3.1 Global Drug Coated Stent Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Drug Coated Stent Global Drug Coated Stent Sales by Region: 2019-2030
3.2.1 Global Drug Coated Stent Sales by Region: 2019-2024
3.2.2 Global Drug Coated Stent Sales by Region: 2025-2030
3.3 Global Drug Coated Stent Global Drug Coated Stent Revenue by Region: 2019-2030
3.3.1 Global Drug Coated Stent Revenue by Region: 2019-2024
3.3.2 Global Drug Coated Stent Revenue by Region: 2025-2030
3.4 North America Drug Coated Stent Market Facts & Figures by Country
3.4.1 North America Drug Coated Stent Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Drug Coated Stent Sales by Country (2019-2030)
3.4.3 North America Drug Coated Stent Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Drug Coated Stent Market Facts & Figures by Country
3.5.1 Europe Drug Coated Stent Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Drug Coated Stent Sales by Country (2019-2030)
3.5.3 Europe Drug Coated Stent Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drug Coated Stent Market Facts & Figures by Country
3.6.1 Asia Pacific Drug Coated Stent Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Drug Coated Stent Sales by Country (2019-2030)
3.6.3 Asia Pacific Drug Coated Stent Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Drug Coated Stent Market Facts & Figures by Country
3.7.1 Latin America Drug Coated Stent Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Drug Coated Stent Sales by Country (2019-2030)
3.7.3 Latin America Drug Coated Stent Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Drug Coated Stent Market Facts & Figures by Country
3.8.1 Middle East and Africa Drug Coated Stent Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Drug Coated Stent Sales by Country (2019-2030)
3.8.3 Middle East and Africa Drug Coated Stent Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Drug Coated Stent Sales by Type (2019-2030)
4.1.1 Global Drug Coated Stent Sales by Type (2019-2024)
4.1.2 Global Drug Coated Stent Sales by Type (2025-2030)
4.1.3 Global Drug Coated Stent Sales Market Share by Type (2019-2030)
4.2 Global Drug Coated Stent Revenue by Type (2019-2030)
4.2.1 Global Drug Coated Stent Revenue by Type (2019-2024)
4.2.2 Global Drug Coated Stent Revenue by Type (2025-2030)
4.2.3 Global Drug Coated Stent Revenue Market Share by Type (2019-2030)
4.3 Global Drug Coated Stent Price by Type (2019-2030)
5 Segment by Application
5.1 Global Drug Coated Stent Sales by Application (2019-2030)
5.1.1 Global Drug Coated Stent Sales by Application (2019-2024)
5.1.2 Global Drug Coated Stent Sales by Application (2025-2030)
5.1.3 Global Drug Coated Stent Sales Market Share by Application (2019-2030)
5.2 Global Drug Coated Stent Revenue by Application (2019-2030)
5.2.1 Global Drug Coated Stent Revenue by Application (2019-2024)
5.2.2 Global Drug Coated Stent Revenue by Application (2025-2030)
5.2.3 Global Drug Coated Stent Revenue Market Share by Application (2019-2030)
5.3 Global Drug Coated Stent Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Biosensors International
6.1.1 Biosensors International Corporation Information
6.1.2 Biosensors International Description and Business Overview
6.1.3 Biosensors International Drug Coated Stent Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Biosensors International Drug Coated Stent Product Portfolio
6.1.5 Biosensors International Recent Developments/Updates
6.2 Abbott Laboratories
6.2.1 Abbott Laboratories Corporation Information
6.2.2 Abbott Laboratories Description and Business Overview
6.2.3 Abbott Laboratories Drug Coated Stent Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Abbott Laboratories Drug Coated Stent Product Portfolio
6.2.5 Abbott Laboratories Recent Developments/Updates
6.3 Advantec Vascular
6.3.1 Advantec Vascular Corporation Information
6.3.2 Advantec Vascular Description and Business Overview
6.3.3 Advantec Vascular Drug Coated Stent Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Advantec Vascular Drug Coated Stent Product Portfolio
6.3.5 Advantec Vascular Recent Developments/Updates
6.4 B. Braun
6.4.1 B. Braun Corporation Information
6.4.2 B. Braun Description and Business Overview
6.4.3 B. Braun Drug Coated Stent Sales, Revenue and Gross Margin (2019-2024)
6.4.4 B. Braun Drug Coated Stent Product Portfolio
6.4.5 B. Braun Recent Developments/Updates
6.5 Biosensors
6.5.1 Biosensors Corporation Information
6.5.2 Biosensors Description and Business Overview
6.5.3 Biosensors Drug Coated Stent Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Biosensors Drug Coated Stent Product Portfolio
6.5.5 Biosensors Recent Developments/Updates
6.6 Biotronik
6.6.1 Biotronik Corporation Information
6.6.2 Biotronik Description and Business Overview
6.6.3 Biotronik Drug Coated Stent Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Biotronik Drug Coated Stent Product Portfolio
6.6.5 Biotronik Recent Developments/Updates
6.7 Blue Medical
6.6.1 Blue Medical Corporation Information
6.6.2 Blue Medical Description and Business Overview
6.6.3 Blue Medical Drug Coated Stent Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Blue Medical Drug Coated Stent Product Portfolio
6.7.5 Blue Medical Recent Developments/Updates
6.8 Boston Scientific
6.8.1 Boston Scientific Corporation Information
6.8.2 Boston Scientific Description and Business Overview
6.8.3 Boston Scientific Drug Coated Stent Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Boston Scientific Drug Coated Stent Product Portfolio
6.8.5 Boston Scientific Recent Developments/Updates
6.9 DISA Vascular
6.9.1 DISA Vascular Corporation Information
6.9.2 DISA Vascular Description and Business Overview
6.9.3 DISA Vascular Drug Coated Stent Sales, Revenue and Gross Margin (2019-2024)
6.9.4 DISA Vascular Drug Coated Stent Product Portfolio
6.9.5 DISA Vascular Recent Developments/Updates
6.10 Essen
6.10.1 Essen Corporation Information
6.10.2 Essen Description and Business Overview
6.10.3 Essen Drug Coated Stent Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Essen Drug Coated Stent Product Portfolio
6.10.5 Essen Recent Developments/Updates
6.11 Medtronic Vascular
6.11.1 Medtronic Vascular Corporation Information
6.11.2 Medtronic Vascular Drug Coated Stent Description and Business Overview
6.11.3 Medtronic Vascular Drug Coated Stent Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Medtronic Vascular Drug Coated Stent Product Portfolio
6.11.5 Medtronic Vascular Recent Developments/Updates
6.12 MicroPort Medical
6.12.1 MicroPort Medical Corporation Information
6.12.2 MicroPort Medical Drug Coated Stent Description and Business Overview
6.12.3 MicroPort Medical Drug Coated Stent Sales, Revenue and Gross Margin (2019-2024)
6.12.4 MicroPort Medical Drug Coated Stent Product Portfolio
6.12.5 MicroPort Medical Recent Developments/Updates
6.13 MIV Therapeutics
6.13.1 MIV Therapeutics Corporation Information
6.13.2 MIV Therapeutics Drug Coated Stent Description and Business Overview
6.13.3 MIV Therapeutics Drug Coated Stent Sales, Revenue and Gross Margin (2019-2024)
6.13.4 MIV Therapeutics Drug Coated Stent Product Portfolio
6.13.5 MIV Therapeutics Recent Developments/Updates
6.14 Orbusneich
6.14.1 Orbusneich Corporation Information
6.14.2 Orbusneich Drug Coated Stent Description and Business Overview
6.14.3 Orbusneich Drug Coated Stent Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Orbusneich Drug Coated Stent Product Portfolio
6.14.5 Orbusneich Recent Developments/Updates
6.15 Promed Medical
6.15.1 Promed Medical Corporation Information
6.15.2 Promed Medical Drug Coated Stent Description and Business Overview
6.15.3 Promed Medical Drug Coated Stent Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Promed Medical Drug Coated Stent Product Portfolio
6.15.5 Promed Medical Recent Developments/Updates
6.16 Relisys Medical
6.16.1 Relisys Medical Corporation Information
6.16.2 Relisys Medical Drug Coated Stent Description and Business Overview
6.16.3 Relisys Medical Drug Coated Stent Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Relisys Medical Drug Coated Stent Product Portfolio
6.16.5 Relisys Medical Recent Developments/Updates
6.17 Reva Medical
6.17.1 Reva Medical Corporation Information
6.17.2 Reva Medical Drug Coated Stent Description and Business Overview
6.17.3 Reva Medical Drug Coated Stent Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Reva Medical Drug Coated Stent Product Portfolio
6.17.5 Reva Medical Recent Developments/Updates
6.18 Sahajanand
6.18.1 Sahajanand Corporation Information
6.18.2 Sahajanand Drug Coated Stent Description and Business Overview
6.18.3 Sahajanand Drug Coated Stent Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Sahajanand Drug Coated Stent Product Portfolio
6.18.5 Sahajanand Recent Developments/Updates
6.19 Sino Medical
6.19.1 Sino Medical Corporation Information
6.19.2 Sino Medical Drug Coated Stent Description and Business Overview
6.19.3 Sino Medical Drug Coated Stent Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Sino Medical Drug Coated Stent Product Portfolio
6.19.5 Sino Medical Recent Developments/Updates
6.20 Sorin
6.20.1 Sorin Corporation Information
6.20.2 Sorin Drug Coated Stent Description and Business Overview
6.20.3 Sorin Drug Coated Stent Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Sorin Drug Coated Stent Product Portfolio
6.20.5 Sorin Recent Developments/Updates
6.21 Terumo Medical
6.21.1 Terumo Medical Corporation Information
6.21.2 Terumo Medical Drug Coated Stent Description and Business Overview
6.21.3 Terumo Medical Drug Coated Stent Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Terumo Medical Drug Coated Stent Product Portfolio
6.21.5 Terumo Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drug Coated Stent Industry Chain Analysis
7.2 Drug Coated Stent Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drug Coated Stent Production Mode & Process
7.4 Drug Coated Stent Sales and Marketing
7.4.1 Drug Coated Stent Sales Channels
7.4.2 Drug Coated Stent Distributors
7.5 Drug Coated Stent Customers
8 Drug Coated Stent Market Dynamics
8.1 Drug Coated Stent Industry Trends
8.2 Drug Coated Stent Market Drivers
8.3 Drug Coated Stent Market Challenges
8.4 Drug Coated Stent Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
List of Tables
Table 1. Global Drug Coated Stent Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Drug Coated Stent Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Drug Coated Stent Market Competitive Situation by Manufacturers in 2023
Table 4. Global Drug Coated Stent Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Drug Coated Stent Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Drug Coated Stent Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Drug Coated Stent Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Drug Coated Stent Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Drug Coated Stent, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Drug Coated Stent, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Drug Coated Stent, Product Type & Application
Table 12. Global Key Manufacturers of Drug Coated Stent, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Drug Coated Stent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Coated Stent as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Drug Coated Stent Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Drug Coated Stent Sales by Region (2019-2024) & (K Units)
Table 18. Global Drug Coated Stent Sales Market Share by Region (2019-2024)
Table 19. Global Drug Coated Stent Sales by Region (2025-2030) & (K Units)
Table 20. Global Drug Coated Stent Sales Market Share by Region (2025-2030)
Table 21. Global Drug Coated Stent Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Drug Coated Stent Revenue Market Share by Region (2019-2024)
Table 23. Global Drug Coated Stent Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Drug Coated Stent Revenue Market Share by Region (2025-2030)
Table 25. North America Drug Coated Stent Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Drug Coated Stent Sales by Country (2019-2024) & (K Units)
Table 27. North America Drug Coated Stent Sales by Country (2025-2030) & (K Units)
Table 28. North America Drug Coated Stent Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Drug Coated Stent Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Drug Coated Stent Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Drug Coated Stent Sales by Country (2019-2024) & (K Units)
Table 32. Europe Drug Coated Stent Sales by Country (2025-2030) & (K Units)
Table 33. Europe Drug Coated Stent Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Drug Coated Stent Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Drug Coated Stent Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Drug Coated Stent Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Drug Coated Stent Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Drug Coated Stent Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Drug Coated Stent Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Drug Coated Stent Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Drug Coated Stent Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Drug Coated Stent Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Drug Coated Stent Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Drug Coated Stent Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Drug Coated Stent Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Drug Coated Stent Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Drug Coated Stent Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Drug Coated Stent Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Drug Coated Stent Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Drug Coated Stent Sales (K Units) by Type (2019-2024)
Table 51. Global Drug Coated Stent Sales (K Units) by Type (2025-2030)
Table 52. Global Drug Coated Stent Sales Market Share by Type (2019-2024)
Table 53. Global Drug Coated Stent Sales Market Share by Type (2025-2030)
Table 54. Global Drug Coated Stent Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Drug Coated Stent Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Drug Coated Stent Revenue Market Share by Type (2019-2024)
Table 57. Global Drug Coated Stent Revenue Market Share by Type (2025-2030)
Table 58. Global Drug Coated Stent Price (US$/Unit) by Type (2019-2024)
Table 59. Global Drug Coated Stent Price (US$/Unit) by Type (2025-2030)
Table 60. Global Drug Coated Stent Sales (K Units) by Application (2019-2024)
Table 61. Global Drug Coated Stent Sales (K Units) by Application (2025-2030)
Table 62. Global Drug Coated Stent Sales Market Share by Application (2019-2024)
Table 63. Global Drug Coated Stent Sales Market Share by Application (2025-2030)
Table 64. Global Drug Coated Stent Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Drug Coated Stent Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Drug Coated Stent Revenue Market Share by Application (2019-2024)
Table 67. Global Drug Coated Stent Revenue Market Share by Application (2025-2030)
Table 68. Global Drug Coated Stent Price (US$/Unit) by Application (2019-2024)
Table 69. Global Drug Coated Stent Price (US$/Unit) by Application (2025-2030)
Table 70. Biosensors International Corporation Information
Table 71. Biosensors International Description and Business Overview
Table 72. Biosensors International Drug Coated Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Biosensors International Drug Coated Stent Product
Table 74. Biosensors International Recent Developments/Updates
Table 75. Abbott Laboratories Corporation Information
Table 76. Abbott Laboratories Description and Business Overview
Table 77. Abbott Laboratories Drug Coated Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Abbott Laboratories Drug Coated Stent Product
Table 79. Abbott Laboratories Recent Developments/Updates
Table 80. Advantec Vascular Corporation Information
Table 81. Advantec Vascular Description and Business Overview
Table 82. Advantec Vascular Drug Coated Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Advantec Vascular Drug Coated Stent Product
Table 84. Advantec Vascular Recent Developments/Updates
Table 85. B. Braun Corporation Information
Table 86. B. Braun Description and Business Overview
Table 87. B. Braun Drug Coated Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. B. Braun Drug Coated Stent Product
Table 89. B. Braun Recent Developments/Updates
Table 90. Biosensors Corporation Information
Table 91. Biosensors Description and Business Overview
Table 92. Biosensors Drug Coated Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Biosensors Drug Coated Stent Product
Table 94. Biosensors Recent Developments/Updates
Table 95. Biotronik Corporation Information
Table 96. Biotronik Description and Business Overview
Table 97. Biotronik Drug Coated Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Biotronik Drug Coated Stent Product
Table 99. Biotronik Recent Developments/Updates
Table 100. Blue Medical Corporation Information
Table 101. Blue Medical Description and Business Overview
Table 102. Blue Medical Drug Coated Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Blue Medical Drug Coated Stent Product
Table 104. Blue Medical Recent Developments/Updates
Table 105. Boston Scientific Corporation Information
Table 106. Boston Scientific Description and Business Overview
Table 107. Boston Scientific Drug Coated Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Boston Scientific Drug Coated Stent Product
Table 109. Boston Scientific Recent Developments/Updates
Table 110. DISA Vascular Corporation Information
Table 111. DISA Vascular Description and Business Overview
Table 112. DISA Vascular Drug Coated Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. DISA Vascular Drug Coated Stent Product
Table 114. DISA Vascular Recent Developments/Updates
Table 115. Essen Corporation Information
Table 116. Essen Description and Business Overview
Table 117. Essen Drug Coated Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Essen Drug Coated Stent Product
Table 119. Essen Recent Developments/Updates
Table 120. Medtronic Vascular Corporation Information
Table 121. Medtronic Vascular Description and Business Overview
Table 122. Medtronic Vascular Drug Coated Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Medtronic Vascular Drug Coated Stent Product
Table 124. Medtronic Vascular Recent Developments/Updates
Table 125. MicroPort Medical Corporation Information
Table 126. MicroPort Medical Description and Business Overview
Table 127. MicroPort Medical Drug Coated Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. MicroPort Medical Drug Coated Stent Product
Table 129. MicroPort Medical Recent Developments/Updates
Table 130. MIV Therapeutics Corporation Information
Table 131. MIV Therapeutics Description and Business Overview
Table 132. MIV Therapeutics Drug Coated Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. MIV Therapeutics Drug Coated Stent Product
Table 134. MIV Therapeutics Recent Developments/Updates
Table 135. Orbusneich Corporation Information
Table 136. Orbusneich Description and Business Overview
Table 137. Orbusneich Drug Coated Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Orbusneich Drug Coated Stent Product
Table 139. Orbusneich Recent Developments/Updates
Table 140. Promed Medical Corporation Information
Table 141. Promed Medical Description and Business Overview
Table 142. Promed Medical Drug Coated Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Promed Medical Drug Coated Stent Product
Table 144. Promed Medical Recent Developments/Updates
Table 145. Relisys Medical Corporation Information
Table 146. Relisys Medical Description and Business Overview
Table 147. Relisys Medical Drug Coated Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Relisys Medical Drug Coated Stent Product
Table 149. Relisys Medical Recent Developments/Updates
Table 150. Reva Medical Corporation Information
Table 151. Reva Medical Description and Business Overview
Table 152. Reva Medical Drug Coated Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Reva Medical Drug Coated Stent Product
Table 154. Reva Medical Recent Developments/Updates
Table 155. Sahajanand Corporation Information
Table 156. Sahajanand Description and Business Overview
Table 157. Sahajanand Drug Coated Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. Sahajanand Drug Coated Stent Product
Table 159. Sahajanand Recent Developments/Updates
Table 160. Sino Medical Corporation Information
Table 161. Sino Medical Description and Business Overview
Table 162. Sino Medical Drug Coated Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 163. Sino Medical Drug Coated Stent Product
Table 164. Sino Medical Recent Developments/Updates
Table 165. Sorin Corporation Information
Table 166. Sorin Description and Business Overview
Table 167. Sorin Drug Coated Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 168. Sorin Drug Coated Stent Product
Table 169. Sorin Recent Developments/Updates
Table 170. Terumo Medical Corporation Information
Table 171. Terumo Medical Description and Business Overview
Table 172. Terumo Medical Drug Coated Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 173. Terumo Medical Drug Coated Stent Product
Table 174. Terumo Medical Recent Developments/Updates
Table 175. Key Raw Materials Lists
Table 176. Raw Materials Key Suppliers Lists
Table 177. Drug Coated Stent Distributors List
Table 178. Drug Coated Stent Customers List
Table 179. Drug Coated Stent Market Trends
Table 180. Drug Coated Stent Market Drivers
Table 181. Drug Coated Stent Market Challenges
Table 182. Drug Coated Stent Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Drug Coated Stent
Figure 2. Global Drug Coated Stent Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Drug Coated Stent Market Share by Type in 2023 & 2030
Figure 4. Everolimus-Coated Stent Product Picture
Figure 5. Zotarolimus-Coated Stent Product Picture
Figure 6. Ridaforolimus-Coated Stent Product Picture
Figure 7. SYNERGY Coated Stent Product Picture
Figure 8. Orsiro Coated Stent Product Picture
Figure 9. Global Drug Coated Stent Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Drug Coated Stent Market Share by Application in 2023 & 2030
Figure 11. Angioplasty
Figure 12. Restenosis
Figure 13. Global Drug Coated Stent Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Drug Coated Stent Market Size (2019-2030) & (US$ Million)
Figure 15. Global Drug Coated Stent Sales (2019-2030) & (K Units)
Figure 16. Global Drug Coated Stent Average Price (US$/Unit) & (2019-2030)
Figure 17. Drug Coated Stent Report Years Considered
Figure 18. Drug Coated Stent Sales Share by Manufacturers in 2023
Figure 19. Global Drug Coated Stent Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Drug Coated Stent Players: Market Share by Revenue in 2023
Figure 21. Drug Coated Stent Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Drug Coated Stent Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Drug Coated Stent Sales Market Share by Country (2019-2030)
Figure 24. North America Drug Coated Stent Revenue Market Share by Country (2019-2030)
Figure 25. U.S. Drug Coated Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Drug Coated Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Drug Coated Stent Sales Market Share by Country (2019-2030)
Figure 28. Europe Drug Coated Stent Revenue Market Share by Country (2019-2030)
Figure 29. Germany Drug Coated Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Drug Coated Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Drug Coated Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Drug Coated Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Drug Coated Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Drug Coated Stent Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Drug Coated Stent Revenue Market Share by Region (2019-2030)
Figure 36. China Drug Coated Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Drug Coated Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Drug Coated Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Drug Coated Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Drug Coated Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Taiwan Drug Coated Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Drug Coated Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Drug Coated Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Drug Coated Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Philippines Drug Coated Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Drug Coated Stent Sales Market Share by Country (2019-2030)
Figure 47. Latin America Drug Coated Stent Revenue Market Share by Country (2019-2030)
Figure 48. Mexico Drug Coated Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil Drug Coated Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina Drug Coated Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Drug Coated Stent Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa Drug Coated Stent Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Drug Coated Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Drug Coated Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. U.A.E Drug Coated Stent Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Drug Coated Stent by Type (2019-2030)
Figure 57. Global Revenue Market Share of Drug Coated Stent by Type (2019-2030)
Figure 58. Global Drug Coated Stent Price (US$/Unit) by Type (2019-2030)
Figure 59. Global Sales Market Share of Drug Coated Stent by Application (2019-2030)
Figure 60. Global Revenue Market Share of Drug Coated Stent by Application (2019-2030)
Figure 61. Global Drug Coated Stent Price (US$/Unit) by Application (2019-2030)
Figure 62. Drug Coated Stent Value Chain
Figure 63. Drug Coated Stent Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock